BioWorld MedTech

Jan. 28, 2010

Prostate cancer treatments vary at county vs. private hospitals

Researchers at Moores Cancer Center at the University of California, San Diego (UCSD) and colleagues have found that prostate cancer treatments varied significantly between county hospitals and private providers. (Medical Device Daily) Read More

Halt's fibroid device, procedure to make other treatments 'irrelevant'

International report: Varian Medical certified to assemble X-ray tubes in China

BrandWatch develops marker to spot counterfeit devices

Washington roundup: Prior FDA move on drug tests opposed by Congress and DEA

Today's MDD food for med-tech thought

Financings roundup: HeartWare seeks to raise $50M in public offering of 1.5M shares

Agreements/contracts: Opsens' sensor tech integrated with Abiomed's heart pump

Patent watch: Neurologix gains protection for Parkinson's disease tech

Deals roundup: Imagine Media signs non-binding letter of intent to acquire DMI

Grants roundup: GE gets $3.27M to bring medical imaging to undeveloped countries

Med-Tech Notes

Product Briefs

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 18, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 18, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...